ArticleAnnals of translational medicine2019

Central nervous system activity of first-line osimertinib in epidermal growth factor receptor-mutant advanced non-small cell lung cancer.

Chong-Kin LiamPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.